Wan‐Hsuan Lee

Validation of the prognostic significance of the 2022 European <scp>LeukemiaNet</scp> risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia

Min‐Yen Lo, Chien‐Chin Lin, Feng‐Ming Tien et al. · American Journal of Hematology · 2023 · 40 citations · Full text

Medicine, Oncology, Chemotherapy +9

Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification

Wan‐Hsuan Lee, Ming-Tao Tsai, Cheng‐Hong Tsai et al. · Blood Cancer Journal · 2023 · 26 citations · Full text

Medicine, Hematology, Molecular Medicine +17

Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms

Wan‐Hsuan Lee, Chien‐Chin Lin, Cheng‐Hong Tsai et al. · Blood Cancer Journal · 2024 · 26 citations · Full text

Medicine, Hematology, Pathology +17

Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients

Wan‐Hsuan Lee, Chien‐Chin Lin, Cheng‐Hong Tsai et al. · American Journal of Hematology · 2022 · 18 citations

Life Sciences, Genetics, Oncology +14

Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations

Feng‐Ming Tien, Chi‐Yuan Yao, Cheng‐Hong Tsai et al. · Blood Cancer Journal · 2024 · 16 citations · Full text

Medicine, Hematology, Oncology +16